Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Published:2020-10-12 Issue:11 Volume:26 Page:1686-1690
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Heczey Andras^ORCID,Courtney Amy N.,Montalbano Antonino,Robinson Simon,Liu Ka^ORCID,Li Mingmei,Ghatwai Nisha,Dakhova Olga,Liu Bin,Raveh-Sadka Tali,Chauvin-Fleurence Cynthia N.^ORCID,Xu Xin^ORCID,Ngai Ho,Di Pierro Erica J.,Savoldo Barbara,Dotti Gianpietro^ORCID,Metelitsa Leonid S.^ORCID

Funder

Alex’s Lemonade Stand Foundation for Childhood Cancer

Kuur Therapeutics; Cookies for Kids’ Cancer Foundation

American Cancer Society

Kuur Therapeutics

Cancer Prevention and Research Institute of Texas

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-020-1074-2.pdf

Reference33 articles.

1. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. & Van Kaer, L. NKT cells: what’s in a name? Nat. Rev. Immunol. 4, 231–237 (2004).

2. Savage, A. K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391–403 (2008).

3. Metelitsa, L. S. Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin. Immunol. 140, 119–129 (2011).

4. Metelitsa, L. S. et al. Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J. Exp. Med. 199, 1213–1221 (2004).

5. Song, L. et al. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J. Clin. Invest. 119, 1524–1536 (2009).

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GD2 targeting CAR T cells for neuroblastoma;EJC Paediatric Oncology;2024-12

2. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review;Pathology - Research and Practice;2024-10

3. Bioactive sphingolipids as emerging targets for signal transduction in cancer development;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. CAR-T Cells in the Treatment of Nervous System Tumors;Cancers;2024-08-22

5. Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy;Frontiers in Immunology;2024-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3